Objective: To evaluate the effect of risperidone on cognitive functions after both 6 weeks and 6 months of treatment and to determine whether any improvement on neuropsychological function relates to improvement in psychopa-thology. Method: Patients ’ psychiatric and extrapyramidal symptoms were assessed while they were receiving classical neuroleptic treatment and adjunctive medications. Patients were then reassessed after changing to a new treatment of risperidone. Results: During treatment with risperidone, schizophrenic patients displayed improved performance mainly on attentional components, specifically, selective attention and alertness. Conclusion: In patients who were given risperidone, there was a positive correlation between impr...
Risperidone is a second-generation antipsychotic medications that can significantly improve cognitiv...
Cognitive deficits have been recognized as a central feature of schizophrenia spectrum disorders. Th...
Cognitive deficits are a core feature of schizophrenia. There is ongoing debate on whether cognition...
Objective: Cognitive deficits are major aspect and cause of disability in schizophrenia. Several ne...
Introduction of the antipsychotics of the second generation (SGA) into the therapy of schizophrenia ...
Introduction: A number of research studies have shown that the new generation of neuroleptic medicat...
Contains fulltext : 88705.pdf (publisher's version ) (Closed access)INTRODUCTION: ...
Background: Recently, long-acting injection (LAI) of second-generation antipsychotics has become a v...
Objective: To describe the concept of memory impairment in schizophrenia and the clinical implicatio...
Risperidone can be found in studies of schizophrenic patients which is more effective than haloperid...
To help determine whether sustained attention deficits as measured with the Continuous Performance T...
Schizophrenia is the most prevalent mental disorder in the world, affecting approximately one percen...
AIM: To compare the Neurocognitive effects of typical and atypical antipsychotics among schizophreni...
Schizophrenia is associated with cognitive deficits for which treatments remain elusive. The effects...
Aripiprazole is a D2 and D3 receptor partial agonist that is unlike other second generation antipsyc...
Risperidone is a second-generation antipsychotic medications that can significantly improve cognitiv...
Cognitive deficits have been recognized as a central feature of schizophrenia spectrum disorders. Th...
Cognitive deficits are a core feature of schizophrenia. There is ongoing debate on whether cognition...
Objective: Cognitive deficits are major aspect and cause of disability in schizophrenia. Several ne...
Introduction of the antipsychotics of the second generation (SGA) into the therapy of schizophrenia ...
Introduction: A number of research studies have shown that the new generation of neuroleptic medicat...
Contains fulltext : 88705.pdf (publisher's version ) (Closed access)INTRODUCTION: ...
Background: Recently, long-acting injection (LAI) of second-generation antipsychotics has become a v...
Objective: To describe the concept of memory impairment in schizophrenia and the clinical implicatio...
Risperidone can be found in studies of schizophrenic patients which is more effective than haloperid...
To help determine whether sustained attention deficits as measured with the Continuous Performance T...
Schizophrenia is the most prevalent mental disorder in the world, affecting approximately one percen...
AIM: To compare the Neurocognitive effects of typical and atypical antipsychotics among schizophreni...
Schizophrenia is associated with cognitive deficits for which treatments remain elusive. The effects...
Aripiprazole is a D2 and D3 receptor partial agonist that is unlike other second generation antipsyc...
Risperidone is a second-generation antipsychotic medications that can significantly improve cognitiv...
Cognitive deficits have been recognized as a central feature of schizophrenia spectrum disorders. Th...
Cognitive deficits are a core feature of schizophrenia. There is ongoing debate on whether cognition...